FDA Approves Desmoda for Central Diabetes Insipidus

By News Health
1 hour Ago

(MedPage Today) — The FDA approved desmopressin acetate (Desmoda) oral solution for the management of central diabetes insipidus in adults and children, developer Eton Pharmaceuticals announced.
The vasopressin analog acts as an antidiuretic…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/120090

Author :

Publish date : 2026-02-27 20:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Early Bleeding Alone Not Tied to Pregnancy Loss Risk

Exercise May Up QoL When Taking Chemo for Breast Cancer

AI Vulnerable to Fake Info; Vegetarians Have Fewer Cancers; 'Snooki' Has Cancer

Study Warns of Large Increase in New HIV Cases in U.S. if Ryan White Program Ends

No Major 'Reactions' at FDA's Food Allergy Expert Panel

EMA Backs First Combined mRNA Vaccine for COVID-19 and Flu